DE60226879D1 - Verfahren zur herstellung von 4-(imidazol-1-yl)benzolsulfonamidderivaten - Google Patents

Verfahren zur herstellung von 4-(imidazol-1-yl)benzolsulfonamidderivaten

Info

Publication number
DE60226879D1
DE60226879D1 DE60226879T DE60226879T DE60226879D1 DE 60226879 D1 DE60226879 D1 DE 60226879D1 DE 60226879 T DE60226879 T DE 60226879T DE 60226879 T DE60226879 T DE 60226879T DE 60226879 D1 DE60226879 D1 DE 60226879D1
Authority
DE
Germany
Prior art keywords
formula
preparation
derivatives
benzolsulfonamid
imidazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60226879T
Other languages
English (en)
Inventor
Rosales Carmen Almansa
Gonzalez Concepcion Gonzalez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Palau Pharma SA
Original Assignee
Palau Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Palau Pharma SA filed Critical Palau Pharma SA
Application granted granted Critical
Publication of DE60226879D1 publication Critical patent/DE60226879D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/40—Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C07C311/38—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
    • C07C311/39—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/40—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/68—Halogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE60226879T 2001-08-07 2002-08-01 Verfahren zur herstellung von 4-(imidazol-1-yl)benzolsulfonamidderivaten Expired - Lifetime DE60226879D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200101853A ES2184633B1 (es) 2001-08-07 2001-08-07 Procedimiento para la preparacion de derivados de 4-(imidazol-1-il) bencenosulfonamida.
PCT/ES2002/000385 WO2003016285A1 (es) 2001-08-07 2002-08-01 Procedimiento para la preparacion de derivados de 4-(imidazol-1-il)bencenosulfonamida

Publications (1)

Publication Number Publication Date
DE60226879D1 true DE60226879D1 (de) 2008-07-10

Family

ID=8498662

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60226879T Expired - Lifetime DE60226879D1 (de) 2001-08-07 2002-08-01 Verfahren zur herstellung von 4-(imidazol-1-yl)benzolsulfonamidderivaten

Country Status (17)

Country Link
US (2) US7351836B2 (de)
EP (1) EP1424329B1 (de)
JP (1) JP4309262B2 (de)
KR (1) KR100888905B1 (de)
AR (2) AR037231A1 (de)
AT (1) ATE396976T1 (de)
BR (1) BRPI0211749B8 (de)
CA (1) CA2456531C (de)
CY (1) CY1108861T1 (de)
DE (1) DE60226879D1 (de)
DK (1) DK1424329T3 (de)
ES (2) ES2184633B1 (de)
HK (1) HK1066214A1 (de)
MX (1) MXPA04001147A (de)
NO (1) NO326162B1 (de)
PT (1) PT1424329E (de)
WO (1) WO2003016285A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN2015DN00202A (de) 2012-07-12 2015-06-12 Chiesi Farma Spa
WO2022269384A1 (en) * 2021-06-24 2022-12-29 Ami Organics Ltd. A process for the direct synthesis of fedratinib intermediate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TNSN99111A1 (fr) * 1998-06-11 2005-11-10 Pfizer Derives de sulfonylbenzene nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
DE69935913T2 (de) * 1998-07-02 2008-01-10 Cryptography Research Inc., San Francisco Leckresistente aktualisierung eines indexierten kryptographischen schlüssels
AR024222A1 (es) * 1998-10-16 2002-09-25 Palau Pharma Sa Imidazoles con actividad antiinflamatoria un procedimiento para su preparacion y composiciones farmaceuticas que lo contienen
ES2159489B1 (es) 2000-03-23 2002-04-16 Uriach & Cia Sa J Nuevos derivados de imidazol con actividad antiinflamatoria.

Also Published As

Publication number Publication date
AR086065A2 (es) 2013-11-13
KR20040020079A (ko) 2004-03-06
ES2184633A1 (es) 2003-04-01
US8476456B2 (en) 2013-07-02
MXPA04001147A (es) 2004-07-08
AR037231A1 (es) 2004-11-03
ES2307817T3 (es) 2008-12-01
JP2005502659A (ja) 2005-01-27
CY1108861T1 (el) 2014-08-13
NO326162B1 (no) 2008-10-13
KR100888905B1 (ko) 2009-03-16
CA2456531A1 (en) 2003-02-27
BR0211749B1 (pt) 2013-09-10
WO2003016285A8 (es) 2003-08-28
ATE396976T1 (de) 2008-06-15
EP1424329A1 (de) 2004-06-02
WO2003016285A1 (es) 2003-02-27
EP1424329B1 (de) 2008-05-28
US7351836B2 (en) 2008-04-01
BR0211749A (pt) 2004-10-13
US20090012307A1 (en) 2009-01-08
HK1066214A1 (en) 2005-03-18
NO20040981L (no) 2004-03-05
ES2184633B1 (es) 2004-08-01
BRPI0211749B8 (pt) 2021-05-25
DK1424329T3 (da) 2008-09-29
CA2456531C (en) 2010-12-14
JP4309262B2 (ja) 2009-08-05
PT1424329E (pt) 2008-08-06
US20040242872A1 (en) 2004-12-02

Similar Documents

Publication Publication Date Title
DE60330357D1 (de) Verfahren zur herstellung von 3-halogen-4,5-dihydro-1 h-pyrazolen
WO2002100860A3 (fr) Composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens
DE69915004D1 (de) 5-Oxo-pyrrolidine-2-Carbonsäure-Hydroxamidderivate
DE60137273D1 (de) Verfahren zur Herstellung von 4-Phenoxy chinolin Derivaten
ATE315550T1 (de) Fungizide phenylamidinderivative
TR28332A (tr) Arilasetik asit türevleri.
ATE191317T1 (de) Verwendung von beta-aminopropionsäure-derivaten als fungizide
DE60233664D1 (de) Verfahren zur herstellung von pyridinverbindungen
ATE159728T1 (de) Cis-epoxide derivate, verwendbar als irreversible hiv-protease inhibitoren und verfahren und zwischenprodukte zu ihrer herstellung
DE50212728D1 (de) Verfahren zur herstellung von 2-azetidinonderivaten
DE60226879D1 (de) Verfahren zur herstellung von 4-(imidazol-1-yl)benzolsulfonamidderivaten
DE60310609D1 (de) Verfahren zur herstellung von 2-aminomethylpyridin-derivaten
ATE297902T1 (de) Sulfonyl-pyridazinon-derivate zur verwendung als aldose-reduktase-inhibitoren
DE60108209D1 (de) Fungizide Phenylimidate-Derivate
DE60013515D1 (de) 4-Arylpiperidinderivate zur Behandlung von Pruritus
ATE554094T1 (de) Verfahren zur herstellung von 3-cephem- verbindungen
ATE319708T1 (de) Azol- oder triazol-derivate, verfahren zu deren herstellung und ihre verwendung als fungizide
DE69319356T2 (de) Thiolderivate von Gallensäure
DE69406382T2 (de) Verfahren zur Herstellung von N-Phenyl-N-(4-Piperidinyl)Amid-Derivaten
DE60035925D1 (de) Verfahren zur Herstellung von Cephalosporin-Derivaten
DE50107619D1 (de) Verfahren zur herstellung von 4-brom-anilin-derivaten
ATE231161T1 (de) 6-deoxy-erythromycin-derivate, ihrer herstellung, und ihrer verwendung als arzneimitteln

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC